29/10/2026 - Press release
Cheating in sport through doping is becoming increasingly difficult. And the latest study led by Laboratorio Antidopaje de Cataluña, part of the Hospital del Mar Research Institute (HMRIB), will make it even harder for athletes who seek to improve their performance through fraudulent means. The study, published in the journal Medicine & Science in Sports & Exercise, has validated capillary blood sampling as a tool that is just as effective for detecting potential cases of doping as traditional venous blood sampling.
Més informació "New blood sampling system validated in the fight against doping"
27/10/2026 - General information
The World's Top 2% Scientists ranking, which includes the world's most influential researchers, features 44 professionals affiliated with Hospital del Mar and the Hospital del Mar Research Institute (HMRIB) in its latest edition. The list, compiled by Stanford University in the United States, takes into account the most highly cited scientists across a range of disciplines. Researchers are classified into 22 scientific fields and 174 subfields, and the ranking includes 100,000 individuals, representing the top 2% of active scientists worldwide. The ranking comprises two lists. One takes into account researchers' entire careers, while the other considers only citation data from scientific publications in recent years.
26/10/2026 - General information
The study, published in JAMA Neurology, shows that early communication of blood biomarker results improves diagnostic certainty for Alzheimer's disease and enables optimisation of the clinical management of patients with cognitive symptoms, without having a negative emotional impact. The research analysed the progress of 220 patients in the PLASMAR study, divided according to whether they received their biomarker results after three or nine months. Receiving them earlier made it possible to bring forward clinical decision-making and provide more efficient patient follow-up. The results show that communicating the results early, after three months, also reduced follow-up tests and unnecessary reassessments, particularly in patients with a low probability of Alzheimer's disease, without increasing levels of anxiety, depression or stress.
21/10/2026 - General information
The Societat Catalana de Farmàcia Clínica has awarded the Joaquim Bonal Grant to the project 'Estratègies innovadores per al monitoratge de precisió del linezolid mitjançant biomarcadors no invasius i farmacogenètica', led by Sònia Luque and Pau Riera, from the Pharmacy Department at Hospital del Mar and researchers at the Hospital del Mar Research Institute. This prestigious recognition in the field of clinical pharmacy will support a project aimed at validating non-invasive alternatives for monitoring the antibiotic linezolid and analysing the usefulness of pharmacogenetics to optimise its use. Linezolid is used to treat severe infections caused by multidrug-resistant Gram-positive bacteria. Its prolonged use may be limited by the onset of adverse effects, including haematological toxicity, the incidence of which increases significantly when treatment lasts more than two weeks and is particularly high in patients who require several weeks or months of therapy.
20/10/2026 - Institutional news
Where can science and healthcare professionals meet to share needs and, perhaps, develop projects together? At Translational Matchmaking, an initiative of the Impact Department at the Hospital del Mar Research Institute (HMRIB), in collaboration with the Innovation Unit at Hospital del Mar, held on 19 October at the Barcelona Biomedical Research Park (PRBB). Taking part provided an opportunity to "discover people with similar or complementary interests, but, beyond that, to identify opportunities for collaboration between them and give rise to new research projects that can help people", explains Ismael Ávila, Head of the HMRIB Impact Department. Both researchers from the Institute and healthcare professionals from the hospital took part, forming fourteen pairs who were able to share objectives and find potential partners for future projects.
20/10/2026 - Press release
The risk of a repeat suicide attempt is particularly high during the three months following hospital admission for a suicide attempt, according to the results obtained within the SURVIVE project and published in The Lancet Regional Health Europe. The main risk factors are the patient's mental health conditions and history of suicidal behaviour. A high burden of psychotropic medication and experiences of emotional neglect during childhood also play a role. The researchers believe these findings should lead to a reassessment of the follow-up provided to people treated after a suicide attempt, as well as to a more precise identification of their risk factors.
19/10/26 - General information
From November 23 to 27, Hospital del Mar hosts Innovation Week, a space to share ideas, connect knowledge, and foster new ways of transforming healthcare. Under the concept of iNOVA, the week aims to highlight the innovation generated every day across the Hospital and showcase the people and projects that help drive the organization forward. Research, healthcare, technology, and innovation come together in a programme designed to connect perspectives and create new opportunities.
16/10/2026 - Institutional news
Four projects led by professionals from the Hospital del Mar Research Institute, together with a fifth project involving HMRIB, have been selected in the different funding calls launched by the "la Caixa" Foundation. These include the Health Research, CaixaImpulse Innovation and HealthCare Research calls. These scientific projects address current healthcare challenges, ranging from the generation of scientific knowledge to the development of solutions with social impact. In total, funding has been awarded to eighty initiatives, amounting to €32.4 million.
14/10/2026 - General information
The International Society of Paediatric Oncology (SIOP) has awarded the Odile Schweisguth Award to research on Ewing sarcoma carried out by Dr Irene Cuervas, a researcher at the Hospital del Mar Research Institute and the Sant Joan de Déu Research Institute (IRSJD). The study was co-led by Dr Inmaculada Hernández-Muñoz, a researcher with the Dermatological Inflammatory and Neoplastic Diseases Research Group at HMRIB, and Dr Jaume Mora, head of the Sarcoma and Neuroblastoma Research Group at IRSJD, and was conducted in collaboration with the Centre for Genomic Regulation (CRG).
13/10/2026 - General information
Research in the field of frailty and kidney transplantation, led by the Nephrology and Physical Medicine and Rehabilitation Departments at Hospital del Mar and researchers from the Hospital del Mar Research Institute, has received the Nephrology Research Award at the Íñigo Álvarez de Toledo Awards for Nephrology Research, presented by the Spanish Kidney Foundation. The award jury, made up of 22 experts in nephrology, research and business, granted two awards: one for nephrology and another for nephrology nursing, which, in this edition, was shared by two projects.
Servei de Comunicació:
Marta Calsina(ELIMINAR)
Tel:
(+34) 93 316 06 80
Doctor Aiguader, 88
08226 Barcelona
© Institut Hospital del Mar
d'Investigacions MèdiquesLegal Notice and Privacy Policy | Cookie Policy | Site Index | Accessibility | Find Us | Contact
